> The challenge is not creating a vaccine that stimulates an immune response, the challenge is avoiding a response that makes things worse.
Agreed. This is probably always true, there’s just more concrete evidence of this potential outcome with dengue.
Antibody response is not necessarily the same, even in the same person with the same antigen.
The immune system basically creates a ton of random antibodies and when they “hit” on the previously unseen antigen, they are amplified.
Now once someone has had an immune response and generated memory cells, then yes, very similar antigens (that somewhat bind to the exist ones the body made prior) will tend to “narrow down” the antibodies generated to varieties of the original one (the immune system basically says ‘these old antibodies are close, so let’s create variation off them to optimize the new ones’).
Then the other thing to consider is that there are different strains of dengue - so you could get type A, generate a response, but then exposed to type B where your type A antibodies activate the infection mechanism rather than disable it.
Basically people develop antibodies that make future infections worse by potential infections the infectious proteins.
The challenge is not creating a vaccine that stimulates an immune response, the challenge is avoiding a response that makes things worse.